Travere Therapeutics
TVTX
TVTX
122 hedge funds and large institutions have $874M invested in Travere Therapeutics in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 54 increasing their positions, 37 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $964M → $874M (-$89.7M)
25% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 24
82% less call options, than puts
Call options by funds: $8.56M | Put options by funds: $48M
Holders
122
Holding in Top 10
2
Calls
$8.56M
Puts
$48M
Top Buyers
| 1 | +$20.2M | |
| 2 | +$14.4M | |
| 3 | +$14.3M | |
| 4 |
Millennium Management
New York
|
+$6.71M |
| 5 |
BlackRock
New York
|
+$6.66M |
Top Sellers
| 1 | -$13.4M | |
| 2 | -$11.3M | |
| 3 | -$7.34M | |
| 4 |
SCM
Scopia Capital Management
New York
|
-$6.64M |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$5.87M |